Please login to the form below

Not currently logged in
Email:
Password:

South America

This page shows the latest South America news and features for those working in and with pharma, biotech and healthcare.

MSD launches EU’s first biosimilar Herceptin in UK

MSD launches EU’s first biosimilar Herceptin in UK

The new biosimilar will be sold in Europe by MSD - known as Merck &Co in North America - but was originally developed by South Korean biotech Samsung Bioepis. ... Another South Korean firm - Celltrion - secured EMA backing for its Herzuma version of the

Latest news

More from news
Approximately 1 fully matching, plus 59 partially matching documents found.

Latest Intelligence

  • The ‘Million Hour Challenge’ The ‘Million Hour Challenge’

    This initiative is now under consideration as a long-term programme across South America.

  • Deal Watch February 2017 Deal Watch February 2017

    First approved in North America in 1989, Zoladex sales in 2016 were $69m in the US and Canada and $816m globally. ... Under the original licence Vifor's rights covered Europe, Canada, Mexico, Central and South America and South Korea.

  • A new route to market A new route to market

    also expected from many other Asian countries and also Latin America. ... From Eastern Europe to North America and South East Asia, business cultures vary significantly throughout the world, leading to a demand for specialised management support.

  • Deal Watch December 2015 Deal Watch December 2015

    178. Europe, Latin America and South Africa. 11th January 2016.

  • Pharma deals in June 2015 Pharma deals in June 2015

    For Juno-originated programmes co-developed under the collaboration, Juno will be responsible for R&D and will retain commercialisation rights in North America, whilst Celgene will be responsible for development ... EU and other countries (ex North

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics